Impaired T helper 1 function of nonstructural protein 3-specific T cells in japanese patients with encephalitis with neurological sequelae

Journal of Infectious Diseases

Volumn 189, Issue 5, 2004, Pages 880-891

  Kumar, Priti ^a   Sulochana, Paramadevanapalli ^b   Nirmala, Gejjehalli ^b   Chandrashekar, Ramakrishnappa ^b   Haridattatreya, Magandi ^b   Satchidanandam, Vijaya ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b Vijayanagar Institute of Medical Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; PROTEIN SUBUNIT; SYNAPSIN II;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; IMMUNIZATION; JAPANESE ENCEPHALITIS VIRUS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TRANSPORT; T LYMPHOCYTE; VIRUS ENCEPHALITIS;

ANTIBODY FORMATION; ANTIGENS, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; JAPAN; LYMPHOCYTE ACTIVATION; RNA HELICASES; SERINE ENDOPEPTIDASES; TH1 CELLS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 1542267688     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/381768     Document Type: Article

References (50)

1. Tsai TF, Chang GJ, Yu YX. Japanese encephalitis vaccines. In: Plotkins SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: W.B. Saunders, 1999:672-710.
2. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 1981; 59:895-900.
3. Bradish CJ, Fitzgeorge R, Titmuss D. The responses of normal and athymic mice to infections by togaviruses: strain differentiation in active and adoptive immunization. J Gen Virol 1980; 46:255-65.
4. Mathur A, Arora KL, Chaturvedi UC. Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 1983; 64:805-11.
5. Miura K, Onodera T, Nishida A, Goto N, Fujisaki Y. A single gene controls resistance to Japanese encephalitis virus in mice. Arch Virol 1990; 112: 261-70.
6. + T cells. J Gen Virol 1996; 77:705-14.
7. van der Most RG, Murali-Krishna K, Ahmed R, Strauss JH. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response. J Virol 2000; 74:8094-101.
8. van der Most RG, Murali-Krishna K, Ahmed R. Prolonged presence of effector-memory CD8 T cells in the central nervous system after dengue virus encephalitis. Int Immunol 2003; 15:119-25.
9. - cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 1991; 65:1823-8.
10. - cytotoxic T-cell clones. J Virol 1994; 68:3283-8.
11. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346:1006-7.
12. + cytotoxic T lymphocyte (CTL) clones: recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol 1995; 154:1287-95.
13. + cytotoxic T-lymphocyte clones. J Virol 1996; 70:141-7.
14. Leroux-Roels G, Esquivel CA, DeLeys R, et al. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 1996; 23: 8-16.
15. Mathew A, Kurane I, Green S, et al. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol 1998; 72:3999-4004.
16. Co MD, Terajima M, Cruz J, Ennis FA, Rothman AL. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 2002; 293:151-63.
17. + T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. J Virol 1998; 72:8032-6.
18. Konishi E, Kurane I, Mason PW, et al. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine 1998; 16:842-9.
19. Desai A, Ravi V, Chandramuki A, Gourie-Devi M. Proliferative response of human peripheral blood mononuclear cells to Japanese encephalitis virus. Microbiol Immunol 1995; 39:269-73.
20. Konishi E, Kurane I, Mason PW, Innis BL, Ennis FA. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 1995; 53:278-83.
21. Kumar P, Uchil PD, Sulochana P, et al. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol 2003; 148:1569-91.
22. Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods 2001; 24:247-56.
23. Ravi V, Vanajakshi S, Gowda A, Chandramuki A. Laboratory diagnosis of Japanese encephalitis using monoclonal antibodies and correlation of findings with the outcome. J Med Virol 1989; 29:221-3.
24. Ting SH, See E, Tan HC, Lee MA, Ooi EE. Development of a simplified assay for the detection of neutralizing antibodies to Japanese encephalitis virus. J Virol Methods 2001; 93:43-7.
25. Rao-Bhau LN, Singh G, Gowal D, et al. Safety & efficacy of Japanese encephalitis vaccine produced in India. Indian J Med Res 1988; 88:301-7.
26. + T cells to gamma interferon production in human tuberculosis. Infect Immun 2001; 69:3497-501.
27. + T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect Immun 2003; 71:1929-37.
28. Kumar R, Mathur A, Singh KB, et al. Clinical sequelae of Japanese encephalitis in children. Indian J Med Res 1993; 97:9-13.
29. Jung MC, Hartmann B, Gerlach JT, et al. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 1999; 261:165-72.
30. Yang KD, Yeh WT, Yang MY, Chen RF, Shaio MF. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol 2001; 63:150-7.
31. Shibagaki N, Udey MC. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol 2002; 168:2393-401.
32. Billoir F, de-Chesse R, Tolou H, de-Micco P, Gould EA, de-Lamballerie X. Phylogeny of the genus flavivirus using complete coding sequences of arthropod-borne viruses and viruses with no known vector. J Gen Virol 2000; 81:781-90.
33. Lobigs M, Arthur CE, Mullbacher A, Blanden RV. The flavivirus non-structural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 1994; 202:195-201.
34. Regner M, Lobigs M, Blanden RV, Milburn P, Mullbacher A. Antiviral cytotoxic T cells cross-reactively recognize disparate peptide determinants from related viruses but ignore more similar self-and foreign determinants. J Immunol 2001; 166:3820-8.
35. - cytotoxic T lymphocyte clones. J Gen Virol 1995; 76:2243-9.
36. + T-cell clones. J Virol 1996; 70: 3108-17.
37. Monath TP, Levenbook I, Soike K, et al. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol 2000; 74:1742-51.
38. Chen HW, Pan CH, Huan HW, Liau MY, Chiang JR, Tao MH. Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12-expressing plasmid. J Immunol 2001; 166:7419-26.
39. + lymphocytes. J Virol 2001; 75:2107-18.
40. Licon Luna RM, Lee E, Mullbacher A, Blanden RV, Langman R, Lobigs M. Lack of both fas ligand and perform protects from flavivirus-mediated encephalitis in mice. J Virol 2002; 76:3202-11.
41. Patterson CE, Lawrence DM, Echols LA, Rall GF. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 2002; 76: 4497-506.
42. Komatsu T, Srivastava N, Revzin M, Ireland DD, Chesler D, Shoshkes-Reiss C. Mechanisms of cytokine-mediated inhibition of viral replication. Virology 1999; 259:334-41.
43. Parra B, Hinton DR, Marten NW, et al. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999; 162:1641-7.
44. Binder GK, Griffin DE. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 2001; 293:303-6.
45. Clerici M, Shearer GM. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107-11.
46. Chaturvedi UC, Elbishbishi EA, Agarwal R, et al. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 1999; 59:335-40.
47. Mangada MM, Endy TP, Nisalak A, et al. Dengue-specific T cell responses in peripheral blood mononudear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 2002; 185:1697-703.
48. Kesson AM, Blanden RV, Mullbacher A. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J Gen Virol 1987; 68:2001-6.
49. + cytotoxic T-cell responses. J Virol 2001; 75:11457-63.
50. + T cell help in generating functional CD8 T cell memory. Science 2003; 300:337-9.